Prescription of Psychotropic Medication to People with Intellectual Disabilities in Primary Health-care Settings

Journal of Applied Research in Intellectual Disabilities

Volumn 12, Issue 1, 1999, Pages 46-57

  Molyneux, Philip ^a   Emerson, Eric ^b   Caine, Amenda ^a  

^a PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033438556     PISSN: 13602322     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3148.1999.tb00049.x     Document Type: Article

References (36)

1. Ahmed, Z., Allen, D., Emerson, E., Felce, D., Fraser, W.I., Kerr, M.P., Kiernan, C., Patel, P., Rowe, S., Baxter, H., Robertson, J.M., and Thomas, J. (1997) The Effects of Reducing Antipsychotic Medication in People with a Learning Disability. Cardiff. University of Wales College of Medicine.
2. Aman, M.G., Field, C.J. and Bridgeman, G. (1985) City wide survey of drug patterns amongst non-institutionalized mentally retarded persons. Applied Research in Mental Retardation 6, 159-71.
3. Aman, M.G. and Singh, N.N. (1988) Psychopharmacology of the Developmental Disabilities. Springer-Verlag: New York.
4. Bodfish, J.W. and Madison, J.T. (1993) Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation. American Journal on Mental Retardation 98, 360-67.
5. Branford, D. (1994) A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. Journal of Intellectual Disability Research 38, 577-86.
6. Branford, D. (1996) Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities. Journal of Intellectual Disability Research 40, 322-9.
7. Briggs, R. (1989) Monitoring and evaluating psychotropic drug use for persons with Mental Retardation: A follow-up report. American Journal on Mental Retardation 93, 633-9.
8. Chadsey-Rusch, J. and Sprague, R.L. (1989) Maladaptive behaviors associated with neuroleptic drug maintenance. American Journal of Mental Retardation 93, 607-17.
9. Clarke, D. (1997) Towards rational psychotropic prescribing for people with learning disability. British Journal of Learning Disabilities 25, 46-52.
10. Clarke, D.J., Kelley, S., Thinn, K. and Corbett, J. (1990) Psychotropic drugs and mental retardation: Disabilities and the prescription of drugs for behaviour and for epilepsy in three settings. Journal of Mental Deficiency Research 34, 385-95.
11. Deb, S. and Fraser, W.I. (1994) The use of psychotropic medication in people with learning disability: Towards rational prescribing. Human Psychopharmacology 9, 259-72.
12. Emerson, E., Alborz, A., Kiernan, C., Mason, H., Reeves, D., Swarbrick, R. and Mason, L. (1997) The HARC Challenging Behaviour Project. Report 5: Treatment, Management and Service Utilisation. Manchester Hester Adrian Research Centre, University of Manchester.
13. Fielding, L.T., Murphy, R.J., Reagan, M.W. and Peterson, T.L. (1980) An assessment program to reduce drug use with the mentally retarded. Hospital and Community Psychiatry 31, 771-3.
14. Findholt, N.E. and Emmett, C.G. (1990) Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation. Mental Retardation 28, 41-6.
15. Fischbacher, E. (1987) Prescribing in a hospital for the mentally retarded. Journal of Mental Deficiency Research 31, 17-49.
16. Fleming, I., Caine, A., Ahmed, S. and Smith, S. (1996) Aspects of the use of psychoactive medication among people with intellectual disabilities who have been resettled from long-stay hospitals into dispersed housing. Journal of Applied Research in Intellectual Disabilities 9, 194-205.
17. Fraser, W.I., Leudar, I., Gray, J. and Campbell, L. (1986) Psychiatric behaviour disorder in mental handicap. Journal of Mental Deficiency Research 30, 49-59.
18. Harper, D.C. and Wandsworth, J.S. (1993) Behavioral problems and medication utilisation. Mental Retardation 31, 97-103.
19. Harvey, R.J. and Cooray, S.E. (1993) Neuroleptic drug usage in a community mental handicap unit. Psychiatric Bulletin 17, 657-60.
20. Intagliata, J. and Rinck, C. (1985) Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacology Bulletin 21, 268-78.
21. Kiernan, C., Reeves, D. and Alborz, A. (1995) The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. Journal of Intellectual Disability Research 39, 263-74.
22. Kohen, D., Mathew, G. and Fernando, L. (1993) Survey of psychotropic medication: Usage in a large mental handicap hospital. Psychiatric Bulletin 17, 137-39.
23. Lader. M. and Herrington, R. (1996) Biological Treatments in Psychiatry (2nd edn) (pp. 48-62). Oxford: Oxford University Press.
24. LaMendola, W., Zaharia, E.S. and Carver, M. (1980) Reducing psychotropic drug use in an institution for the retarded. Hospital and Community Psychiatry 31, 271-2.
25. Lewis, M.H., Bodfish, J.W., Powell, S.B. and Golden, R.N. (1995) Clomipramine treatment for stereotypy and related repetitive movement disorders associated with mental retardation. American Journal on Mental Retardation 100, 299-312.
26. Lewis, M.H., Bodfish, J.W., Powell, S.B., Parker, D.E. and Golden, R.N. (1996) Clomipramine treatment for self-injurious behavior of individuals with mental retardation: A double-blind comparison with placebo. American Journal on Mental Retardation 100, 654-65.
27. Luchins, D.J., Dojka, D. and Hanrahan, P. (1993) Factors associated with reduction in antipsychotic medication dosage in adults with mental retardation. American Journal on Mental Retardation 98, 165-75.
28. Markowitz, P. (1992) Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study. Journal of Clinical Psychopharmacology 12, 27-31.
29. Russell, O. (1997) The diagnosis of psychiatric disorders. In O. Russell (ed.) The Psychiatry of Learning Disabilities (pp. 48-62). London: Gaskell.
30. Singh, N.N. and Aman, M.G. (1981) Effects of thioridazine dosage on the behavior of severely mentally retarded persons. American Journal of Mental Deficiency 85, 580-7.
31. Singh, N.N. and Repp, A.C. (1989) The behavioural and pharmacological management of problem behaviours in people with mental retardation. Irish Journal of Psychology 9, 264-85.
32. Sovner, R., Fox, C.J., Lowry, M.J. and Lowry, M.A. (1993) Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research 37, 301-11.
33. Stone, R.K., Alvarez, W.F., Ellman, G., Hom, A.C. and White, J.F. (1989) Prevalence and prediction of psychotropic drug use in California Developmental Centers. American Journal of Mental Deficiency 93, 627-32.
34. Thompson, T., Hackenberg, T. and Schaal, D. (1991) Pharmacological treatments for behavior problems in developmental disabilities. In US Department of Health and Human Services (ed.) Treatment of Destructive Behaviors in Persons with Developmental Disabilities (pp. 343-445). Bethesda, MD: National Institutes of Health.
35. Wressel, S., Tyrer, S. and Berney, T. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients. British Journal of Psychiatry 157, 101-6.
36. Zimmerman, R.L. and Heistad, G.T. (1982) Studies of the long-term efficacy of antipsychotic drugs in controlling the behavior of institutionalized retardates. Journal of the American Academy of Child Psychiatry 21, 136-43.